Jul 16, 2025
Tempus Receives U.S. FDA 510(k) Clearance for Tempus ECG-Low EF Software
Jul 08, 2025
Insulet to Announce Second Quarter 2025 Financial Results on August 7, 2025
Jul 08, 2025
Trividia Health, Inc. Announces Preferred Listing of the TRUE METRIX® Blood Glucose Meter and Test Strips for Pennsylvania’s Medicaid Recipients
May 12, 2025
Rockwell Medical Announces First Quarter 2025 Results
Apr 03, 2025
Meitheal Pharmaceuticals Announces Approval and Launch of Liraglutide Injection in the United States
Apr 03, 2025
Fluor to Provide EPCM Services for a Second Multi-Billion-Dollar Pharmaceutical Facility in Indiana
Mar 25, 2025
Redwire Awarded NASA Contract to Expand Pharmaceutical Drug Development in Space for Future Commercialization
Mar 18, 2025
New Multinational Study Shows MRI is Cost-Effective in the Diagnosis and Management of Steatotic Liver Disease
Jan 13, 2025
Cytovance Biologics and PolyPeptide Announce Collaboration for Microbial and Mammalian-Expressed Peptide Drugs
Nov 26, 2024
Geistlich Announces Exclusive Distribution Partnership for its Leading Wound Care Portfolio in the United States
Nov 01, 2024
Insulet Announces Array of Activities to Support National Diabetes Awareness Month and World Diabetes Day in November  
Oct 02, 2024
Trividia Health, Inc. Announces Preferred Listing in Florida
Sep 06, 2024
Endoscopy Market Insights & Forecast 2024-2028, Featuring Profiles of Leading Players Ethicon Endo-Surgery Inc., Medtronic, Fujifilm, Boston Scientific, Olympus and Ambu - ResearchAndMarkets.com
Apr 03, 2024
Insulet to Announce First Quarter 2024 Financial Results on May 9, 2024
Mar 11, 2024
Akston Biosciences' AKS-107 Study Published in Frontiers in Immunology, Displaying Ambifect® Platform’s Versatility
Mar 08, 2024
Insulet’s Randomized Controlled Trial (OP5-003) Demonstrates Omnipod® 5 Automated Insulin Delivery System is Superior to Pump Therapy
Mar 05, 2024
Insulet to Present Results from First Omnipod® 5 Randomized Controlled Trial (OP5-003) at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)
Feb 23, 2024
Insulet Reports Full Year 2023 Revenue Increase of 30% (30% Constant Currency1) and Fourth Quarter 2023 Revenue Increase of 38% Year-Over-Year (37% Constant Currency)
Feb 14, 2024
Insulet to Present at The Raymond James & Associates 45th Annual Institutional Investors Conference
Jan 18, 2024
National Stem Cell Foundation Travels with Axiom Space Mission to Continue Innovative Neurodegeneration Research on the International Space Station